The new medical domain concerns composite sequences. Such synthetic entities integrate sections of various peptide origins, allowing the development of distinct pharmacological characteristics. This approach provides a https://chimerapeptides128307.my21blog.com/833257/chimera-peptides-a-novel-therapeutic-frontier